GLPcompareGLPcompare
DrugsPricesCompareShortagesEvidenceSupplementsWatchlist
HomeManufacturersNovo Nordisk
Manufacturer

Novo Nordisk GLP-1 medications

GLP-1 medications from Novo Nordisk, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC
2approved
2in development

Approved medicines

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

GLP-1

Liraglutide

Victoza, Saxenda

Subcutaneous injection · Once daily

FDA shortage reportIn shortage

Published entry quote

~$372/mo

Generic liraglutide 3 mg pens (Saxenda generic), GoodRx coupon · GoodRx

Checked Sep 30, 2026

Price conditions

GoodRx coupon, lowest listed price for one carton of five 18 mg/3 mL pens

GoodRx lists brand Saxenda separately; this is its generic liraglutide listing (Teva launched the first generic GLP-1 for weight loss in August 2025). Prices vary by pharmacy.

Third-party reported price.

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety
GLP-1

Semaglutide

Ozempic, Wegovy, Wegovy HD, Rybelsus

Subcutaneous injection (Ozempic, Wegovy); oral tablet (Rybelsus, oral Ozempic, Wegovy pill) · Once weekly (injectable); once daily (oral)

FDA shortage report

Published entry quote

$149-$299/mo

Wegovy pill (oral semaglutide) via GoodRx · GoodRx

Checked Sep 30, 2026

Price conditions

Investigational (pipeline)

Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.

Amylin/GLP-1Phase 3

Amycretin

Amycretin (investigational)

Subcutaneous injection and oral tablet (both in development) · Once weekly (injectable); once daily (oral)

Investigational. No FDA-approved purchase option.

Study evidence & development
Amylin/GLP-1FDA review
Other manufacturers
Eli Lilly5AstraZeneca1Altimmune1Amgen1Boehringer Ingelheim1Innovent Biologics1Structure Therapeutics1Viking Therapeutics1Zealand Pharma1All GLP-1 drugs
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.
GLPcompareGLPcompare

The live, fully-cited reference for the GLP-1 ecosystem. Every figure traces to its source. Informational only, not medical advice.

Product

  • Drugs
  • Prices
  • Compare
  • Shortages
  • Evidence
  • Supplements

Legal

  • Methodology
  • About
  • News
  • Price updates
  • Privacy Policy
  • Terms of Service
  • Support

Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.

© 2026 GLPcompare. All rights reserved.

Fazier

by dose; Novo Nordisk's self-pay price through a GoodRx coupon

The same oral semaglutide and prices as the NovoCare offer: $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg), per Novo Nordisk's published self-pay ladder. FDA-approved product.

30-day supply

Third-party reported price.

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

CagriSema

CagriSema (investigational)

Subcutaneous injection · Once weekly

Investigational. No FDA-approved purchase option.

Study evidence & development
Browse
IndicationsDrug classesCompare head-to-head